fda 503a bulks list bpc-157 category 2 Exciting news for peptides coming out of today's committee hearing! The Pharmacy Compounding Advisory Committee voted 8-6 to recommend adding BPC- 157 to the for use in compounding for 3 FOR 3. An FDA

3 FOR 3. An FDA advisory committee has now voted 86, with one abstention, to recommend BPC 157, KPV and TB 500 for inclusion on the 503A Bulks List. This is not FDA approval FDA Removes 12 Peptides from 503A List, PCAC Review to Follow Kurt Lunkwitz posted on the topic LinkedIn FDA Pharmacy Compounding Committee Votes on Peptide Policy John Hoekman posted on the topic LinkedIn FDA's own advisory committee voted 8 6 Thursday. BPC 157, on the compounding list now, for ulcerative colitis. FDA staff argued against it, laid out the data gaps, the whole case. Panel overruled them

SKU: 66943955040 · From cantondelareina.com.ar